Professor David Thomas

Professor David Thomas is CEO of Omico: the Australian Genomic Cancer Medicine Centre and inaugural Director of the Centre for Molecular Oncology at UNSW. He undertook his medical training at the University of Melbourne (1982-1988), followed by post-graduate training as a Fellow of the Royal Australasian College of Physicians in Medical Oncology (awarded 1997). He undertook his doctoral studies at the University of Melbourne, and was awarded his PhD in 1997.

David undertook post-doctoral research at Harvard Medical School (1998-2000), before moving back to Melbourne to set up his own laboratory, initially at St Vincent’s Hospital (2001-2003), then at Peter MacCallum Cancer Centre (2002-2014).

He was the founding Chair and board member of the Australasian Sarcoma Study Group (2007-18). He was the Director of the adolescent and young adult (AYA) cancer program, onTrac@PeterMac (2005-2010). In 2018, he was the President of the Connective Tissue Oncology Society. He heads the Garvan Institute of Medical Research’s Genomic Cancer Medicine Laboratory.

In 2018, he established Omico, the Australian Genomic Cancer Medicine Centre.